Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorDetoc, Maëlle-
Autor(es): dc.creatorBruel, Sébastien-
Autor(es): dc.creatorFrappe, Paul-
Autor(es): dc.creatorTardy, Bernard-
Autor(es): dc.creatorBotelho-Nevers, Elisabeth-
Autor(es): dc.creatorGagneux-Brunon, Amandine-
Data de aceite: dc.date.accessioned2026-02-09T11:47:11Z-
Data de disponibilização: dc.date.available2026-02-09T11:47:11Z-
Data de envio: dc.date.issued2020-10-06-
Data de envio: dc.date.issued2020-10-06-
Data de envio: dc.date.issued2020-10-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/43325-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S0264410X20312019-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1147431-
Descrição: dc.descriptionIntroduction The world is facing the COVID-19 pandemic. The development of a vaccine is challenging. We aimed to determine the proportion of people who intend to get vaccinated against COVID-19 in France or to participate in a vaccine clinical trial. Methods We conducted an anonymous on-line survey from the 26th of March to the 20th of April 2020. Primary endpoints were the intention to get vaccinated against COVID-19 if a vaccine was available or participate in a vaccine clinical trial. Results Three thousand two hundred and fifty nine individuals answered the survey; women accounted for 67.4% of the respondents. According to their statements, 2.512 participants (77.6%, 95% CI 76.2–79%) will certainly or probably agree to get vaccinated against COVID-19. Older age, male gender, fear about COVID-19, being a healthcare worker and individual perceived risk were associated with COVID-19 vaccine acceptance. Vaccine hesitancy was associated with a decrease in COVID-19 vaccine acceptance. One thousand and five hundred and fifty respondents (47.6% 95% CI 45.9–49.3%) will certainly or probably agree to participate in a COVID-19 vaccine clinical trial. Older age, male gender, being a healthcare worker and individual perceived risk were associated with potential acceptance to participate in a COVID-19 vaccine clinical trial. Vaccine hesitancy was associated with refusal for participation in a COVID-19 vaccine clinical trial. Conclusions Nearly 75% and 48% of the survey respondents were respectively likely to accept vaccination or participation in a clinical trial against COVID-19. Vaccine hesitancy will be the major barrier to COVID-19 vaccine uptake.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceVaccine-
Palavras-chave: dc.subjectCOVID-19 - Vaccine-
Palavras-chave: dc.subjectVaccine hesitanc-
Palavras-chave: dc.subjectPandemic-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Título: dc.titleIntention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.